In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database

NCT03479762 · Completed

Last updated 2026-05-28

This study looked at how liraglutide, a medication used for weight management, is prescribed and used in real-world settings among adults in the UK who are overweight or have obesity.

Status Completed The study has finished.

Type Observational

Participants 105 people

Who can join all sexes

Timeline Started 2018-04 · est. completion 2022-09

Where 1 site · Denmark

What this study is testing ClinicalTrials.gov NCT03479762 ↗

Description as written by the study sponsor.

This study is conducted in Europe. The aim of this study is to investigate the usage of liraglutide for weight management in clinical practice using the CPRD (Clinical Practice Research Datalink) primary care database.

Treatments tested

Liraglutide Drug

No treatment given

Main thing measured	Number of patients with a BMI above or equal to 30 kg/m^2 (Saxenda® only)
Sponsor	Novo Nordisk A/S
Conditions studied	Obesity, Overweight
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT03479762 ↗